Similar articles

• Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay.

  Tourinho RS, Amado LA, Villar LM, Sampaio DV, Moraes AC, Rodrigues do Ó KM, Gaspar AM, de Paula VS. Tourinho RS, et al. J Virol Methods. 2011 May;173(2):169-74. doi: 10.1016/j.jviromet.2011.01.014. Epub 2011 Feb 3. J Virol Methods. 2011. PMID: 21295610
• High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.

  Ahmed M, Munshi SU, Nessa A, Ullah MS, Tabassum S, Islam MN. Ahmed M, et al. Indian J Med Microbiol. 2009 Jan-Mar;27(1):48-50. Indian J Med Microbiol. 2009. PMID: 19172060
• [Is it necessary to investigate anti-hepatitis A virus (HAV) IgM antibodies when the hepatic enzymogram is normal?].

  Coitinho C, Marroche D, Toscanini C. Coitinho C, et al. Rev Argent Microbiol. 2007 Jul-Sep;39(3):166-9. Rev Argent Microbiol. 2007. PMID: 17990376 Spanish.
• [Specific and non-specific host defense system against hepatitis A virus (HAV) and mechanism of HAV infection].

  Baba M, Hasegawa H. Baba M, et al. Nihon Rinsho. 2004 Aug;62 Suppl 8:438-47. Nihon Rinsho. 2004. PMID: 15453362 Review. Japanese. No abstract available.
• Epaxal: a virosomal vaccine to prevent hepatitis A infection.

  Bovier PA. Bovier PA. Expert Rev Vaccines. 2008 Oct;7(8):1141-50. doi: 10.1586/14760584.7.8.1141. Expert Rev Vaccines. 2008. PMID: 18844588 Review.